A Plus Biotechnology Co., Ltd. (TPE:6918)
Taiwan · Delayed Price · Currency is TWD 74.10
-0.10 (-0.13%)
At close: Jul 9, 2026
A Plus Biotechnology Market Cap
A Plus Biotechnology has a market cap or net worth of 2.52 billion as of July 9, 2026. Its market cap has decreased by -27.95% in one year.
Market Cap
2.52B
Enterprise Value
2.09B
Revenue
858.89M
Ranking
n/a
PE Ratio
14.47
Stock Price
74.10
Market Cap Chart
Since January 6, 2023, A Plus Biotechnology's market cap has increased from 1.52B to 2.52B, an increase of 65.71%. That is a compound annual growth rate of 15.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 2.52B | -14.59% |
| Dec 31, 2025 | 2.96B | 20.95% |
| Dec 31, 2024 | 2.44B | 77.04% |
| Dec 29, 2023 | 1.38B | -9.40% |
| Jan 6, 2023 | 1.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| WeLeader Biomedical | 3.22B |
| Bonraybio | 2.93B |
| Wellell | 2.37B |
| Applied BioCode | 2.34B |
| Medimaging Integrated Solution | 2.33B |
| OK Biotech | 2.22B |
| Dynamic Medical Technologies | 2.04B |
| Taiwan Biomaterial | 1.65B |